PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$12.93M
Total Shares
11.24M
Net Share Change
+9.78M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Patient Capital Management
$12.93M11.24M shares
ADD+9.78M(+668.1%)